Mometasone Furoate Monohydrate (Sandoz Inc.)


Welcome to the PulseAid listing for the Mometasone Furoate Monohydrate drug offered from Sandoz Inc.. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sandoz Inc.
NON-PROPRIETARY NAME: Mometasone Furoate Monohydrate
SUBSTANCE NAME: MOMETASONE FUROATE MONOHYDRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: NASAL
DOSAGE FORM: SPRAY, METERED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2016-03-25
END MARKETING DATE: 0000-00-00


Mometasone Furoate Monohydrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMometasone Furoate Monohydrate from Sandoz Inc.
LABELER NAME: Sandoz Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50(ug/1)
START MARKETING DATE: 2016-03-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0781-6355_45d004ce-a813-4c68-b805-edd708bf028d
PRODUCT NDC: 0781-6355
APPLICATION NUMBER: NDA020762

Other MOMETASONE FUROATE MONOHYDRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Merck Sharp & Dohme Corp.NASONEX
REMEDYREPACK INC.NASONEX
Sandoz Inc.Mometasone Furoate Monohydrate